Cargando…

Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review

Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that oftentimes requires complex therapy. Poor adherence is a major barrier to AD treatment success. An interspecialty, virtual roundtable panel was held, through which clinical dermatologists, allergists, and behavioral and socia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tier, Heather L., Balogh, Esther A., Bashyam, Arjun M., Fleischer, Alan B., Spergel, Jonathan M., Masicampo, E. J., Kammrath, Lara K., Strowd, Lindsay C., Feldman, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019006/
https://www.ncbi.nlm.nih.gov/pubmed/33599887
http://dx.doi.org/10.1007/s13555-021-00500-4
_version_ 1783674293045952512
author Tier, Heather L.
Balogh, Esther A.
Bashyam, Arjun M.
Fleischer, Alan B.
Spergel, Jonathan M.
Masicampo, E. J.
Kammrath, Lara K.
Strowd, Lindsay C.
Feldman, Steven R.
author_facet Tier, Heather L.
Balogh, Esther A.
Bashyam, Arjun M.
Fleischer, Alan B.
Spergel, Jonathan M.
Masicampo, E. J.
Kammrath, Lara K.
Strowd, Lindsay C.
Feldman, Steven R.
author_sort Tier, Heather L.
collection PubMed
description Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that oftentimes requires complex therapy. Poor adherence is a major barrier to AD treatment success. An interspecialty, virtual roundtable panel was held, through which clinical dermatologists, allergists, and behavioral and social psychologists discussed AD management and adherence. Relevant literature was reviewed, and the content of this article was organized based on the roundtable discussion. Current guidelines for AD treatment include maintenance and acute therapy for mild-to-severe AD. Therapy is often complex and requires significant patient involvement, which may contribute to poor treatment adherence. Behavioral and social psychology strategies that may help improve adherence include scheduling timely follow-up appointments, using a clearly written eczema action plan (EAP), reducing perceived treatment burden, utilizing anchoring techniques, sharing anecdotes, and rewarding children using positive reinforcement and stickers. There are multiple practical ways by which providers can improve both the management and treatment adherence of patients with AD.
format Online
Article
Text
id pubmed-8019006
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-80190062021-04-16 Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review Tier, Heather L. Balogh, Esther A. Bashyam, Arjun M. Fleischer, Alan B. Spergel, Jonathan M. Masicampo, E. J. Kammrath, Lara K. Strowd, Lindsay C. Feldman, Steven R. Dermatol Ther (Heidelb) Review Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that oftentimes requires complex therapy. Poor adherence is a major barrier to AD treatment success. An interspecialty, virtual roundtable panel was held, through which clinical dermatologists, allergists, and behavioral and social psychologists discussed AD management and adherence. Relevant literature was reviewed, and the content of this article was organized based on the roundtable discussion. Current guidelines for AD treatment include maintenance and acute therapy for mild-to-severe AD. Therapy is often complex and requires significant patient involvement, which may contribute to poor treatment adherence. Behavioral and social psychology strategies that may help improve adherence include scheduling timely follow-up appointments, using a clearly written eczema action plan (EAP), reducing perceived treatment burden, utilizing anchoring techniques, sharing anecdotes, and rewarding children using positive reinforcement and stickers. There are multiple practical ways by which providers can improve both the management and treatment adherence of patients with AD. Springer Healthcare 2021-02-18 /pmc/articles/PMC8019006/ /pubmed/33599887 http://dx.doi.org/10.1007/s13555-021-00500-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Review
Tier, Heather L.
Balogh, Esther A.
Bashyam, Arjun M.
Fleischer, Alan B.
Spergel, Jonathan M.
Masicampo, E. J.
Kammrath, Lara K.
Strowd, Lindsay C.
Feldman, Steven R.
Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title_full Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title_fullStr Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title_full_unstemmed Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title_short Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
title_sort tolerability of and adherence to topical treatments in atopic dermatitis: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019006/
https://www.ncbi.nlm.nih.gov/pubmed/33599887
http://dx.doi.org/10.1007/s13555-021-00500-4
work_keys_str_mv AT tierheatherl tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT baloghesthera tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT bashyamarjunm tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT fleischeralanb tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT spergeljonathanm tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT masicampoej tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT kammrathlarak tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT strowdlindsayc tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview
AT feldmanstevenr tolerabilityofandadherencetotopicaltreatmentsinatopicdermatitisanarrativereview